Clinical Trial Update: Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for intra-lymphatic immunotherapy targeting tree pollen allergy shows completed status with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis Due to Tree Pollen
• Allergic Rhinoconjunctivitis

Drugs mentioned

• Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy

Snippet

Sponsor: Christopher Thompson, MD | Conditions: Allergic Rhinitis Due to Tree Pollen, Allergic Conjunctivitis | Phase 2 | Status: COMPLETED | Results posted: 2021-02-26